Science News
Search Results 1 - 10 of 168 recordsCan Telaprevir reduce treatment duration, side-effects and cost?
(2 Sep 2010)Hedwig Kresse, healthcare analyst at Datamonitor, provides expert comment following Vertex Pharmaceuticals announcing results from the phase three Illuminate study: "The Illuminate study results confirm ....
US FDA approves Taxotere injection concentrate formulation
(1 Sep 2010)Sanofi-aventis announces that the US FDA has approved a one-vial formulation of its chemotherapeutic agent Taxotere (docetaxel) injection concentrate. The 1-vial Taxotere is anticipated to become available ....
Reporter vectors to simplify miRNA target validation
(31 Aug 2010)Sigma Life Science and SwitchGear Genomics announce a joint project to develop and distribute a novel microRNA (miRNA) target reporter system. Combining SwitchGear Genomics' expertise with Sigma's ....
Phase three trial to evaluate ARQ 197
(26 Aug 2010)ArQule and Daiichi Sankyo announce that they will move forward with a phase three clinical trial of ARQ 197, a small molecule inhibitor of the c-Met receptor tyrosine kinase, in patients with non-small ....
Carfilzomib could be new treatment for relapsed myeloma patients
(25 Aug 2010)The International Myeloma Foundation (IMF) says promising data suggest a new drug called carfilzomib could become an important new option for patients whose myeloma stops responding to other therapies. ....
MabCure files provisional patent for ovarian cancer antibodies
(24 Aug 2010)MabCure announces it has filed a provisional patent application for its ovarian cancer diagnostic antibodies with the US Patent and Trademark Office. The filing was based on positive results of a recent ....
Funding enables use of Solid 4 for cancer biomarker research
(24 Aug 2010)Life Technologies and University of California at San Diego (UCSD) Moores Cancer Center announces a partnership to use Solid 4 genomic analysis technology in a research program to study chronic lymphocytic ....
US FDA accepts new drug application for Gadovist 1.0
(23 Aug 2010)Bayer announces that the US FDA has accepted for filing a new drug application for gadobutrol injection, a gadolinium-based contrast agent for magnetic resonance imaging (MRI). Gadovist 1.0 (gadobutrol ....
SDC antimicrobial effective against T. mentagrophytes in preclinical tests
(19 Aug 2010)Pure Bioscience announces that based on encouraging preclinical data it has granted two product-specific licenses to pharmaceutical development partner FTA Bioscience for development of a silver dihydrogen ....
Physical, socioeconomic and psychological burdens of Psoriasis
(18 Aug 2010)According to recent data from a phase three study, the burden faced by psoriasis patients is a growing worldwide concern. Psoriasis is a non-contagious skin disease that affects 80 million people worldwide. ....
